Alex A. Gandhi

1.4k total citations · 1 hit paper
12 papers, 891 citations indexed

About

Alex A. Gandhi is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Alex A. Gandhi has authored 12 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Rheumatology. Recurrent topics in Alex A. Gandhi's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Blood disorders and treatments (3 papers) and Inflammasome and immune disorders (3 papers). Alex A. Gandhi is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Blood disorders and treatments (3 papers) and Inflammasome and immune disorders (3 papers). Alex A. Gandhi collaborates with scholars based in United States, China and Mexico. Alex A. Gandhi's co-authors include Jason S. Knight, Srilakshmi Yalavarthi, Ramadan A. Ali, Shanea K. Estes, Yogendra Kanthi, Gautam Sule, Yu Zuo, Kelsey Gockman, Melanie Zuo and Jacqueline A. Madison and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and International Journal of Molecular Sciences.

In The Last Decade

Alex A. Gandhi

12 papers receiving 877 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

2020 405 citations Yu Zuo, Shanea K. Estes et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex A. Gandhi United States	10	367	323	240	214	198	12	891
Gautam Sule United States	14	348 0.9×	304 0.9×	170 0.7×	280 1.3×	181 0.9×	18	943
Shigeru Tanaka Japan	18	100 0.3×	349 1.1×	200 0.8×	221 1.0×	68 0.3×	59	963
Naomi I. Maria Netherlands	15	127 0.3×	421 1.3×	408 1.7×	191 0.9×	71 0.4×	24	1.1k
Galina Marder United States	11	98 0.3×	216 0.7×	341 1.4×	116 0.5×	98 0.5×	26	706
Arianna Damiani Italy	13	133 0.4×	180 0.6×	251 1.0×	66 0.3×	47 0.2×	55	633
Y. Shoenfeld Israel	15	64 0.2×	274 0.8×	224 0.9×	85 0.4×	75 0.4×	38	842
António Marinho Portugal	22	48 0.1×	429 1.3×	357 1.5×	228 1.1×	62 0.3×	92	1.3k
Mohamad Zaidan France	16	103 0.3×	72 0.2×	196 0.8×	237 1.1×	40 0.2×	47	851
Rufei Lu United States	16	78 0.2×	447 1.4×	528 2.2×	97 0.5×	46 0.2×	24	874
A Corvetta Italy	15	85 0.2×	195 0.6×	274 1.1×	107 0.5×	26 0.1×	36	763

Countries citing papers authored by Alex A. Gandhi

Since Specialization

Citations

This map shows the geographic impact of Alex A. Gandhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex A. Gandhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex A. Gandhi more than expected).

Fields of papers citing papers by Alex A. Gandhi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex A. Gandhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex A. Gandhi. The network helps show where Alex A. Gandhi may publish in the future.

Co-authorship network of co-authors of Alex A. Gandhi

This figure shows the co-authorship network connecting the top 25 collaborators of Alex A. Gandhi. A scholar is included among the top collaborators of Alex A. Gandhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex A. Gandhi. Alex A. Gandhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Shi, Hui, Yu Zuo, Sherwin Navaz, et al.. (2022). Endothelial Cell–Activating Antibodies in COVID‐19. Arthritis & Rheumatology. 74(7). 1132–1138. 55 indexed citations

2.

Ali, Ramadan A., Shanea K. Estes, Alex A. Gandhi, et al.. (2021). Defibrotide Inhibits Antiphospholipid Antibody–Mediated Neutrophil Extracellular Trap Formation and Venous Thrombosis. Arthritis & Rheumatology. 74(5). 902–907. 32 indexed citations

3.

Shi, Hui, Alex A. Gandhi, Stephanie A. Smith, et al.. (2021). Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide. JCI Insight. 6(17). 28 indexed citations

4.

Gandhi, Alex A., et al.. (2021). Understanding the Pathophysiology of Thrombotic APS through Animal Models. International Journal of Molecular Sciences. 22(5). 2588–2588. 13 indexed citations

5.

Ali, Ramadan A., Alex A. Gandhi, Lipeng Dai, et al.. (2020). Antineutrophil properties of natural gingerols in models of lupus. JCI Insight. 6(3). 28 indexed citations

6.

Zuo, Yu, Shanea K. Estes, Ramadan A. Ali, et al.. (2020). Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Science Translational Medicine. 12(570). 405 indexed citations breakdown →

7.

Ali, Ramadan A., Alex A. Gandhi, He Meng, et al.. (2019). Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nature Communications. 10(1). 1916–1916. 155 indexed citations

8.

Knight, Jason S., He Meng, Patrick Coit, et al.. (2017). Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target. JCI Insight. 2(18). 84 indexed citations

9.

Yalavarthi, Srilakshmi, Alex A. Gandhi, Carlos A. Núñez‐Álvarez, et al.. (2016). Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome. Annals of the Rheumatic Diseases. 76(2). 450–457. 55 indexed citations

10.

Ott, Patrick A., Kathleen Madden, Xin Cheng, et al.. (2012). Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial. Cancer Chemotherapy and Pharmacology. 71(1). 183–191. 34 indexed citations

11.

Ott, Patrick A., et al.. (2011). Abraxane, temozolomide, and oblimersen (The ATG Trial): A final report of toxicity and clinical efficacy in metastatic melanoma patients with normal lactate dehydrogenase (LDH).. Journal of Clinical Oncology. 29(15_suppl). 8545–8545. 1 indexed citations

12.

Pavlick, Anne C., Patrick A. Ott, Juliet Escalon, et al.. (2009). Survival of advanced melanoma patients with normal LDH treated with oblimersen, temozolomide, and nab-paclitaxel. Journal of Clinical Oncology. 27(15_suppl). 9080–9080. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact